The opinion in support of the decision being entered today was not written for publication and is not binding precedent of the Board. UNITED STATES PATENT AND TRADEMARK OFFICE __________ BEFORE THE BOARD OF PATENT APPEALS AND INTERFERENCES __________ Ex parte GREGORY DONOHO, JOHN SCOVILLE, C. ALEXANDER TURNER, JR., GLENN FRIEDRICH, BRIAN ZAMBROWICZ, and ARTHUR T. SANDS __________ Appeal 2004-1103 Application 09/733,387 __________ ON BRIEF __________ Before SCHEINER, ADAMS, and GRIMES, Administrative Patent Judges. ADAMS, Administrative Patent Judge. DECISION ON REQUEST FOR REHEARING Appellants request reconsideration (rehearing) of the Board’s June 30, 2004 Decision, affirming the rejection of claim 1 under 35 U.S.C. § 101 as lacking utility and § 112, first paragraph, for lack of enablement based on the finding of lack of utility. Claims 2, 3, and 6-9 fell together with claim 1.1 Claim 1 is illustrative of the subject matter on appeal and is reproduced below: 1. An isolated nucleic acid molecule comprising at least 22 contiguous bases of nucleotide sequence from SEQ ID NO:43. 1 Having disposed of all claims on appeal, we did not reach the merits of the separate rejection of claim 1 under both the enablement and written description provisions of 35 U.S.C. § 112, first paragraph.Page: 1 2 3 4 5 6 7 Next
Last modified: September 9, 2013